Free Access
Editorial
| Issue |
Med Sci (Paris)
Volume 32, Number 12, Décembre 2016
|
|
|---|---|---|
| Page(s) | 1049 - 1050 | |
| Section | Éditorial | |
| DOI | https://doi.org/10.1051/medsci/20163212001 | |
| Published online | 03 January 2017 | |
Med Sci (Paris) 2016 ; 32 : 1049–1050
Un modèle alternatif et innovant de Recherche et Développement pour garantir l’accès aux médicaments
Maladies négligées, populations négligées et système d’innovation biomédicale
An alternative and innovative Research and Development model to ensure access to medicines – Neglected diseases, neglected populations, and biomedical innovation system
Drugs for Neglected Diseases initiative (DNDi, initiative Médicaments contre les maladies négligées) Chemin Louis-Dunant 15 1202 Genève, Suisse
Cet article ne possède pas de résumé.
© 2016 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
First page of the article
